Examining biology and pharmacology-based hypotheses in the PLATO trial.
Becker
Richard C
RC
Division of Cardiology, Duke University School of Medicine, Durham, USA. becke021@mc.duke.edu
D000241:Adenosine / Q000031:analogs & derivatives* / Q000494:pharmacology; D000818:Animals; D002986:Clinical Trials as Topic; D004285:Dogs; D004617:Embolism; D004912:Erythrocytes / Q000737:chemistry; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D018048:Receptors, Purinergic P2; D013552:Swine; D000077486:Ticagrelor
D010975:Platelet Aggregation Inhibitors; D018048:Receptors, Purinergic P2; D000077486:Ticagrelor; D000241:Adenosine